IP Library Assignment 019868/0463
Patent Assignment
Reel/Frame 019868/0463

Assignment of Assignor's Interest

Recorded: 2007-09-24 Pages: 2
Assignors
HAHN, SUNGTACK SAMUEL
Executed: 2003-05-12
RIEHL, PETER R.
Executed: 2003-05-16
Assignee
STELLAR INTERNATIONAL INC.
82 WELLINGTON STREET SOUTH, SUITE 201, LONDON, ONTARIO, N6B 2K3, CANADA
Covered Property (1)
Cystitis Treatment with High Dose Chondroitin Sulfate
Patent: 7,772,210 →
Application: 10/546,511 →
Publication: US 2006/0194757
Related Assignments (10)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger Sep 24, 2007
From: STELLAR INTERNATIONAL INC.
To: STELLAR PHARMACEUTICALS INC.
Reel/Frame 019868/0757 →
Security Agreement May 25, 2012
From: STELLAR PHARMACEUTICALS INC.; TRIBUTE PHARMACEUTICALS CANADA LTD.; TRIBUTE PHARMA CANADA INC.
To: MIDCAP FUNDING III, LLC, AS AGENT
Reel/Frame 028275/0357 →
Merger Feb 21, 2013
From: STELLAR PHARMACEUTICALS INC.
To: TRIBUTE PHARMACEUTICALS CANADA INC.
Reel/Frame 029849/0376 →
Confirmation of Intellectual Property Security Agreement Recorded at Reel 28275, Frame 0357 Mar 20, 2013
From: TRIBUTE PHARMACEUTICALS CANADA INC.
To: MIDCAP FUNDING III, LLC, AS AGENT
Reel/Frame 030049/0126 →
Security Agreement Aug 8, 2013
From: TRIBUTE PHARACEUTICALS CANADA LLC
To: SWK FUNDING LLC
Reel/Frame 030988/0171 →
Release of Security Interest Aug 27, 2013
From: MIDCAP FUNDING III, LLC
To: TRIBUTE PHARMACEUTICALS CANADA INC.
Reel/Frame 031093/0486 →
Release of Security Interest Feb 5, 2016
From: SWK FUNDING LLC
To: TRIBUTE PHARMACEUTICALS CANADA, INC.
Reel/Frame 037674/0301 →
Change of Name Mar 7, 2018
From: TRIBUTE PHARMACEUTICALS CANADA INC.
To: ARALEZ PHARMACEUTICALS CANADA INC.
Reel/Frame 045518/0563 →
Security Interest Dec 31, 2018
From: NUVO PHARMACEUTICALS INC.; NUVO PHARMACEUTICALS (IRELAND) DESIGNATED ACTIVITY COMPANY; ARALEZ PHARMACEUTICALS CANADA INC.
To: DEERFIELD PRIVATE DESIGN FUND III, L.P., AS AGENT
Reel/Frame 047875/0410 →
Release of Security Interest Mar 14, 2023
From: DEERFIELD PRIVATE DESIGN FUND III, L.P., AS AGENT
To: NUVO PHARMACEUTICALS INC.; ARALEZ PHARMACEUTICALS CANADA INC.; NUVO PHARMACEUTICALS (IRELAND) DESIGNATED ACTIVITY COMPANY (F/K/A NUVO PHARMACEUTICALS (IRELAND) LIMITED)
Reel/Frame 062974/0236 →